[ad_1]
New York, April 18, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Human Microbiome Market by Product, Application, Disease, Research Technology – Global Forecast to 2029” – https://www.reportlinker.com/p03567498/?utm_source=GNW
However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market’s growth.
• By product segment, the drugs segment accounted for the largest share of human microbiome market:
Based on product, the human microbiome market is segmented into probiotics, prebiotics, diagnostic tests, drugs, and other products. Drugs segment accounted for the largest product segment in the human microbiome market. The large share of this segment can be attributed to the increasing number of human microbiome-based drug products in clinical trials and rising funding to develop microbiome-based drugs
By application, the diagnostics segment is expected to grow at the highest CAGR during the forecast period.
Based on application, the human microbiome market is segmented into therapeutics and diagnostics. The diagnostics segment is expected to grow at the highest CAGR during the forecast period.
Advances in life science research on a wide number of diseases, technological innovations in human genome mapping, the emergence of omics technologies, and the increasing emphasis on improving the cost-effectiveness of healthcare and patient outcomes are some …
Full story available on Benzinga.com
[ad_2]
Source link
